Nextech, a Swiss biotech investment firm focused on cancer treatments, is reportedly preparing to begin talks with corporations to be LPs in its next fund.

Alfred Scheidegger (pictured), founding partner of Nextech, said it could essentially act as the “outsourced” venture arm of a corporation, according to news provider Private Equity News (disclosure: I used to edit the magazine title).

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?